T J Giordano

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi request reprint Classification of adrenal cortical tumors: promise of the 'molecular' approach
    Thomas J Giordano
    University of Michigan Medical School, Department of Pathology, MSRB2, C570D, Ann Arbor, MI 48109, United States
    Best Pract Res Clin Endocrinol Metab 24:887-92. 2010
  2. pmc Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles
    T J Giordano
    Department of Pathology, The University of Michigan, Ann Arbor, Michigan 48109 0054, USA
    Am J Pathol 159:1231-8. 2001
  3. ncbi request reprint Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma
    C G Kleer
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, USA
    Mod Pathol 13:742-6. 2000
  4. ncbi request reprint Management of patients with adrenal cancer: recommendations of an international consensus conference
    D E Schteingart
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA
    Endocr Relat Cancer 12:667-80. 2005
  5. doi request reprint Transcriptome analysis of endocrine tumors: clinical perspectives
    T J Giordano
    Department of Pathology, University of Michigan Health System, 1150 W Medical Center Drive, Ann Arbor, MI 48109 0669, USA
    Ann Endocrinol (Paris) 69:130-4. 2008
  6. ncbi request reprint Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome
    D E Schteingart
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 86:3968-74. 2001
  7. ncbi request reprint Identification and management of intravagal parathyroid adenoma
    T M Pawlik
    Section of Endocrine Surgery, Department of Surgery, University of Michigan Medical Center, 2920 Taubman Health Care Center, 1500 E Medical Center Drive, Ann Arbor, Michigan 48109, USA
    World J Surg 25:419-23. 2001
  8. ncbi request reprint Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast
    C G Kleer
    Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109 0054, USA
    Mod Pathol 14:185-90. 2001
  9. ncbi request reprint Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer
    F Le Naour
    Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Clin Cancer Res 7:3328-35. 2001
  10. ncbi request reprint Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma
    C T Miller
    Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Oncogene 25:409-18. 2006

Detail Information

Publications11

  1. doi request reprint Classification of adrenal cortical tumors: promise of the 'molecular' approach
    Thomas J Giordano
    University of Michigan Medical School, Department of Pathology, MSRB2, C570D, Ann Arbor, MI 48109, United States
    Best Pract Res Clin Endocrinol Metab 24:887-92. 2010
    ..Recent advances towards a molecular classification of adrenal cortical tumors are presented and discussed...
  2. pmc Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles
    T J Giordano
    Department of Pathology, The University of Michigan, Ann Arbor, Michigan 48109 0054, USA
    Am J Pathol 159:1231-8. 2001
    ....
  3. ncbi request reprint Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma
    C G Kleer
    Department of Pathology, University of Michigan Medical Center, Ann Arbor, USA
    Mod Pathol 13:742-6. 2000
    ..Primary SCT is an aggressive neoplasm that may be found in association with TCV. p53 expression and high MIB1 labeling index occur in these tumors and may be useful prognosticators...
  4. ncbi request reprint Management of patients with adrenal cancer: recommendations of an international consensus conference
    D E Schteingart
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, USA
    Endocr Relat Cancer 12:667-80. 2005
    ..Anti-angiogenic substances have only been applied in preclinical studies. The use of these and other agents in the treatment of adrenal cancer should be hypothesis-driven and based on a thorough analysis of tumor biology...
  5. doi request reprint Transcriptome analysis of endocrine tumors: clinical perspectives
    T J Giordano
    Department of Pathology, University of Michigan Health System, 1150 W Medical Center Drive, Ann Arbor, MI 48109 0669, USA
    Ann Endocrinol (Paris) 69:130-4. 2008
    ..Here, some of the microarray studies that support the clinical use of transcriptome profiling for endocrine tumors are reviewed. In addition, some of the barriers to clinical implementation are discussed...
  6. ncbi request reprint Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome
    D E Schteingart
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    J Clin Endocrinol Metab 86:3968-74. 2001
    ..Through their angiogenic and chemotactic properties these chemokines may play an important role in adrenal tumorigenesis...
  7. ncbi request reprint Identification and management of intravagal parathyroid adenoma
    T M Pawlik
    Section of Endocrine Surgery, Department of Surgery, University of Michigan Medical Center, 2920 Taubman Health Care Center, 1500 E Medical Center Drive, Ann Arbor, Michigan 48109, USA
    World J Surg 25:419-23. 2001
    ..Examination of the vagus nerve should therefore be strongly considered when four normal glands are found, as intravagal adenomas appear to represent accessory ectopically located parathyroid tissue...
  8. ncbi request reprint Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast
    C G Kleer
    Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109 0054, USA
    Mod Pathol 14:185-90. 2001
    ..Neither Ki-67 nor p53 can reliably predict recurrence. Histologically high-grade malignant PT have a favorable prognosis if widely excised. We emphasize the importance of adequate margins in the treatment of benign and malignant PT...
  9. ncbi request reprint Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer
    F Le Naour
    Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Clin Cancer Res 7:3328-35. 2001
    ..CONCLUSION: The presence of autoantibodies and/or circulating RS/DJ-1 protein in sera from patients with breast cancer may have clinical utility...
  10. ncbi request reprint Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma
    C T Miller
    Department of Surgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    Oncogene 25:409-18. 2006
    ..The data indicate that upregulation of the MET pathway may contribute to the poor outcome of EA patients and that therapeutic agents targeting this pathway may help improve patient survival...
  11. pmc An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer
    F M Brichory
    Department of Pediatrics, University of Michigan, Ann Arbor 48109, USA
    Proc Natl Acad Sci U S A 98:9824-9. 2001
    ..The proteomic approach we have implemented has utility for the development of serum-based assays for cancer diagnosis as we report in this paper on the discovery of antiannexins I and/or II in sera from patients with lung cancer...